Cleavage by granzyme B is strongly predictive of autoantigen status: Implications for initiation of autoimmunity

Journal of Experimental Medicine

Volumn 190, Issue 6, 1999, Pages 815-825

  Casciola Rosen, Livia ^a   Andrade, Felipe ^a   Ulanet, Danielle ^a   Wong, Wes Bang ^a   Rosen, Antony ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Caspase; Cytotoxic T lymphocyte; Protease

Indexed keywords

AUTOANTIGEN; CASPASE; GRANZYME B;

APOPTOSIS; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ENZYME ACTIVE SITE; ENZYME SPECIFICITY; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION;

APOPTOSIS; AUTOANTIGENS; AUTOIMMUNITY; CYTOTOXICITY, IMMUNOLOGIC; GRANZYMES; HELA CELLS; HUMANS; SERINE ENDOPEPTIDASES; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0033588955     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.190.6.815     Document Type: Article

References (50)

1. Hardin, J.A., D.R. Rahn, C. Shen, M.R. Lerner, S.L. Wolin, M.D. Rosa, and J.A. Steitz. 1982. Antibodies from patients with connective tissue diseases bind specific subsets of cellular RNA-protein particles. J. Clin. Invest. 70:141-147.
2. Tan, E.M. 1989. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv. Immunol. 44:93-151.
3. Casciola-Rosen, L.A., G. Anhalt, and A. Rosen. 1994. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med. 179:1317-1330.
4. Mamula, M.J. 1993. The inability to process a self-peptide allows autoreactive T cells to escape tolerance. J. Exp. Med. 177:567-571.
5. Sercarz, E.E., P.V. Lehmann, A. Ametani, G. Benichou, A. Miller, and K. Moudgil. 1993. Dominance and crypticity of T cell antigenic determinants. Annu. Rev. Immunol. 11:729-766.
6. Casciola-Rosen, L.A., D.K. Miller, G.J. Anhalt, and A. Rosen. 1994. Specific cleavage of the 70-kDa protein component of the U1 small nuclear ribonucleoprotein is a characteristic biochemical feature of apoptotic cell death. J. Biol. Chem. 269:30757-30760.
7. Casciola-Rosen, L.A., G.J. Anhalt, and A. Rosen. 1995. DNA-dependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis. J. Exp. Med. 182:1625-1634.
8. Greidinger, E.L., D.K. Miller, T.-T. Yamin, L. Casciola-Rosen, and A. Rosen. 1996. Sequential activation of three distinct ICE-like activities in Fas-ligated Jurkat cells. FEBS Lett. 390:299-303.
9. Casiano, C.A., S.J. Martin, D.R. Green, and E.M. Tan. 1996. Selective cleavage of nuclear autoantigens during CD95 (Fas/APO-1)-mediated T cell apoptosis. J. Exp. Med. 184:765-770.
10. Utz, P.J., M. Hottelet, T.M. Le, S.J. Kim, M.E. Geiger, W.J. van Venrooij, and P. Anderson. 1998. The 72-kDa component of signal recognition particle is cleaved during apoptosis. J. Biol. Chem. 273:35362-35370.
11. Cryns, V., and J. Yuan. 1998. Proteases to die for. Genes Dev. 12:1551-1570.
12. Izquierdo, M., A. Grandien, L.M. Criado, S. Robles, E. Leonardo, J.P. Albar, G.G. de Buitrago, and A.C. Martinez. 1999. Blocked negative selection of developing T cells in mice expressing the baculovirus p35 caspase inhibitor. EMBO (Eur. Mol. Biol Organ.) J. 18:156-166.
13. Rosen, A., and L. Casciola-Rosen. 1999. Autoantigens as substrates for apoptotic proteases: implications for the pathogenesis of systemic autoimmune disease. Cell Death Differ. 6:6-12.
14. Shi, L., C.-M. Kam, J.C. Powers, R. Aebersold, and A.H. Greenberg. 1992. Purification of three cytotoxic lymphocyte granule serine proteases that induce apoptosis through distinct substrate and target cell interactions. J. Exp. Med. 176: 1521-1529.
15. Heusel, J.W., R.L. Wesselschmidt, S. Shresta, J.H. Russell, and T.J. Ley. 1994. Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell. 76:977-987.
16. Shresta, S., D.M. MacIvor, J.W. Heusel, J.H. Russell, and T.J. Ley. 1995. Natural killer and lymphokine-activated killer cells require granzyme B for the rapid induction of apoptosis in susceptible target cells. Prof. Natl. Acad. Sci. USA. 92:5679-5683.
17. Henkart, P.A. 1994. Lymphocyte-mediated cytotoxicity: two pathways and multiple effector molecules. Immunity. 1:343-346.
18. Shresta, S., C.T. Pham, D.A. Thomas, T.A. Graubert, and T.J. Ley. 1998. How do cytotoxic lymphocytes kill their targets? Curr. Opin. Immunol. 10:581-587.
19. Sarin, A., M.S. Williams, M.A. Alexander-Miller, J.A. Berzofsky, C.M. Zacharchuk, and P.A. Henkart. 1997. Target cell lysis by CTL granule exocytosis is independent of ICE/ Ced-3 family proteases. Immunity. 6:209-215.
20. MacDonald, G., L. Shi, C. Vande Velde, J. Lieberman, and A.H. Greenberg. 1999. Mitochondria-dependent and -independent regulation of granzyme B-induced apoptosis. J. Exp. Med. 189:131-144.
21. Andrade, F., S. Roy, D.W. Nicholson, N.A. Thornberry, A. Rosen, and L. Casciola-Rosen. 1998. Granzyme B directly and efficiently cleaves several downstream substrates: implications for CTL-induced apoptosis. Immunity. 8:451-460.
22. Casciola-Rosen, L., A. Pluta, P. Plotz, K. Nagaraju, A. Cox, S. Morris, and A. Rosen. 1998. hPMS1 is a novel, frequently targeted myositis autoantigen which is cleaved by granzyme B but not by caspases during apoptosis. Arthritis Rheum. 41: S127. (Abstr.)
23. Casciola-Rosen, L.A., D.W. Nicholson, T. Chong, K.R. Rowan, N.A. Thornberry, D.K. Miller, and A. Rosen. 1996. Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death. J. Exp. Med. 183:1957-1964.
24. Utz, P.J., and P. Anderson. 1998. Posttranslational protein modifications, apoptosis, and the bypass of tolerance to autoantigens. Arthritis Rheum. 41:1152-1160.
25. Darmon, A.J., D.W. Nicholson, and R.C. Bleackley. 1995. Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B. Nature. 377:446-448.
26. Chinnaiyan, A.M., W.L. Hanna, K. Orth, H.J. Duan, G.G. Poirier, C.J. Froelich, and V.M. Dixit. 1996. Cytotoxic T-cell-derived granzyme B activates the apoptotic protease ICE-LAP3. Curr. Biol. 6:897-899.
27. Quan, L.T., M. Tewari, K. O'Rourke, V. Dixit, S.J. Snipas, G.G. Poirier, C. Ray, D.J. Pickup, and G.S. Salveson. 1996. Proteolytic activation of the cell death protease Yama/ CPP32 by granzyme B. Proc. Natl. Acad. Sci. USA. 93:1972-1976.
28. Martin, S.J., G.P. Amarente-Mendes, L.F. Shi, T.H. Chuang, C.A. Casiano, G.A. O'Brien, P. Fitzgerald, E.M. Tan, G.M. Bokoch, A.H. Greenberg, et al. 1996. The cytotoxic cell protease granzyme B initiates apoptosis in a cell-free system by proteolytic processing and activation of the ICE/CED-3 family protease, CPP32, via a novel two-step mechanism. EMBO (Eur. Mol. Biol. Organ.) J. 15:2407-2416.
29. Thornberry, N.A., T.A. Ranon, E.P. Pieterson, D.M. Rasper, T. Timkey, M. Garcia-Calvo, V.M. Houtzager, P.A. Nordstrom, S. Roy, J.P. Vaillancourt, et al. 1997. A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J. Biol. Chem. 272: 17907-17911.
30. Harris, J.L., E.P. Peterson, D. Hudig, N.A. Thornberry, and C.S. Craik. 1998. Definition and redesign of the extended substrate specificity of granzyme B. J. Biol. Chem. 273: 27364-27373.
31. Froelich, C.J., W.L. Hanna, G.G. Poirier, P.J. Duriez, D. D'Amours, G.S. Salvesen, E.S. Alnemn, W.C. Earnshaw, and G.M. Shah. 1996. Granzyme B perforin-mediated apoptosis of jurkat cells results in cleavage of poly(ADP-ribose) polymerase to the 89-kDa apoptotic fragment and less abundant 64-kDa fragment. Biochem. Biophys. Res. Commun. 227: 658-665.
32. Nagata, S. 1997. Apoptosis by death factor. Cell. 88:355-365.
33. Salvesen, G.S., and V.M. Dixit. 1997. Caspases: intracellular signaling by proteolysis. Cell. 91:443-446.
34. Nicholson, D.W., and N.A. Thornberry. 1997. Caspases: killer proteases. TIBS (Trends Biochem. Sci.). 22:299-306.
35. Beidler, D.R., M. Tewari, P.D. Friesen, G. Poirier, and V.M. Dixit. 1995. The baculovirus p35 protein inhibits Fas-and tumor necrosis factor-induced apoptosis. J. Biol. Chem. 270:16526-16528.
36. Bump, N.J., M. Hackett, M. Hugunin, S. Seshagiri, K. Brady, P. Chen, C. Ferenz, S. Franklin, T. Ghayur, P. Li, et al. 1995. Inhibition of ICE family proteases by baculovirus antiapoptotic protein p35. Science. 269:1885-1888.
37. Deveraux, Q.L., N. Roy, H.R. Stennicke, T. Van Arsdale, Q. Zhou, S.M. Srinivasula, E.S. Alnemri, G.S. Salvesen, and J.C. Reed. 1998. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO (Eur. Mol. Biol. Organ.) J. 17:2215-2223.
38. Srinivasula, S.M., M. Ahmad, S. Ottilie, F. Bullrich, S. Banks, Y. Wang, T. Fernandes-Alnemri, C.M. Croce, G. Litwack, K.J. Tomaselli, et al. 1997. FLAME-1, a novel FADD-like anti-apoptotic molecule that regulates Fas/ TNFR1-induced apoptosis. J. Biol. Chem. 272:18542-18545.
39. Irmler, M., M. Thome, M. Hahne, P. Schneider, B. Hofmann, V. Steiner, J.L. Bodmer, M. Schröter, K. Burns, C. Mattmann, et al. 1997. Inhibition of death receptor signals by cellular FLIP. Nature. 388:190-195.
40. Thome, M., P. Schneider, K. Hofmann, H. Fickenscher, E. Meinl, F. Neipel, C. Mattmann, K. Burns, J.L. Bodmer, M. Schröter, et al. 1997. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature. 386:517-521.
41. Krajewska, M., H.G. Wang, S. Krajewski, J.M. Zapata, A. Shabaik, R. Gascoyne, and J.C. Reed. 1997. Immunohistochemical analysis of in vivo patterns of expression of CPP32 (caspase-3), a cell death protease. Cancer Res. 57: 1605-1613.
42. Krajewski, S., R.D. Gascoyne, J.M. Zapata, M. Krajewska, S. Kitada, M. Chhanabhai, D. Horsman, K. Berean, L.D. Piro, I. Fugier-Vivier, et al. 1997. Immunolocalization of the ICE/Ced-3-family protease, CPP32 (caspase-3), in non-Hodgkin's lymphomas, chronic lymphocytic leukemias, and reactive lymph nodes. Blood. 89:3817-3825.
43. Matzinger, P. 1994. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12:991-1045.
44. Herrmann, M., R.E. Voll, O.M. Zoller, M. Hagenhofer, B.B. Ponner, and J.R. Kalden. 1998. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum. 41:1241-1250.
45. Botto, M., C. Dell'Agnola, A.E. Bygrave, E.M. Thompson, H.T. Cook, F. Petry, M. Loos, P.P. Pandolfi, and M.J. Walport. 1998. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat. Genet. 19:56-59.
46. 5 and CD36 and cross-present antigens to cytotoxic T lymphocytes. J. Exp. Med. 188:1359-1368.
47. Albert, M.L., B. Sauter, and N. Bhardwaj. 1998. Dendritic cells acquire antigen from apoptotic cells and induce class I restricted CTLs. Nature. 392:86-89.
48. Inaba, K., S. Turley, F. Yamaide, T. Iyoda, K. Mahnke, M. Inaba, M. Pack, M. Subklewe, B. Sauter, D. Sheff, et al. 1998. Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J. Exp. Med. 11:2163-2173.
49. Rovere, P., C. Vallinoto, A. Bondaza, M.C. Crosti, M. Rescigno, P. Ricciardi-Castagnoli, C. Rugarli, and A.A. Manfredi. 1998. Bystander apoptosis triggers dendritic cell maturation and antigen-presenting function. J. Immunol. 161: 4467-4471.
50. Albert, M.L., J.C. Darnell, A. Bender, L.M. Francisco, N. Bhardwaj, and R.B. Darnell. 1998. Tumor-specific killer cells in paraneoplastic cerebellar degeneration. Nat. Med. 11: 1321-1324.